Abstract Details

Title Reversible Cerebral Vasoconstriction Syndrome in a Patient Following Dobutamine Stress Echocardiography

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) (-)

Poster/Presentation
Number 134

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Justin Stahl, MD (Virginia Mason Medical Center)	No disclosure on file
Raed Alroughani, MD, FAAN	Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi.
Brad R. Beinlich, MD (Univ of Wisconsin Hospitals)	Dr. Beinlich has nothing to disclose.
	No disclosure on file

��ɫ����